photo.jpg to this folderExecution-first. Therapy-area-grounded. Outcome-obsessed.
Senior Commercial Leader · Healthcare & Pharma APAC
Deepak Chembath spent his formative years in technology and strategy consulting — building analytical rigour at Infosys and ZS Associates — before committing 14 years to pharma commercial leadership. That sequence is not incidental. It is the source of an unusually broad capability set.
At Bayer, he architected the IMS cluster across Indonesia, Malaysia, and Singapore — leading Marketing, Sales, and Commercial Operations across Oncology, Cardiovascular, Women's Health, and Nephrology. Before that, he led Strategy and Commercial Excellence for all of Bayer APAC across 12 markets.
At Abbott India, he led a 90-member commercial team within a USD 1 billion business, executed two full GTM transformations, and pioneered India pharma's first AI chatbot. At ZS Associates, he delivered turnaround strategy for major US pharma brands. And before that — a high-performing technologist at Infosys across the USA and Canada.
He holds an MBA from the Indian School of Business (ISB) and a B.E. in Electrical & Electronics Engineering from the College of Engineering, Guindy (CEG).
Most global commercial strategies treat APAC as an adaptation of a Western playbook. Deepak operates from within — navigating market heterogeneity, fragmented payer landscapes, and the intercultural complexity of leading teams across a dozen distinct markets simultaneously.
From managing a cardiovascular salesforce across rural India to architecting a regional cluster spanning Singapore, Malaysia, and Indonesia — he has built commercial engines that work in the field, not just in the boardroom.
His cross-cultural fluency is not theoretical. It is the product of living and leading across four continents, understanding what motivates teams across cultures, and adapting strategy to local commercial realities without losing regional coherence.
Six capabilities — each grounded in real delivery across APAC's most complex healthcare markets. Strategy that executes in the field, not just in the boardroom.
Real commercial execution is grounded in therapy area realities — disease awareness levels, payer coverage, specialist vs. GP prescribing patterns, diagnostic bottlenecks. Deepak brings that depth as an operator, not as background reading.
Specific results from specific markets — the kind of evidence that matters to senior decision-makers.
Deepak maintains a public book review blog where he writes substantive reviews of books that have shaped his thinking. The reading list reveals the mental models behind the commercial instincts: systems over goals, multidisciplinary frameworks, the power of the right question.
Visit The Change Board →Experienced operators have a responsibility to accelerate the next generation of healthcare innovation — not just optimise existing commercial engines.
Perspectives on commercial leadership, APAC healthcare markets, and what it takes to build execution-ready strategy — shared openly.
Whether you're exploring a potential collaboration, considering an advisory conversation, or simply want to connect with a senior commercial leader who operates at the intersection of strategy, execution, and APAC market depth — the conversation starts here.
He is also open to the right Country GM, CCO, VP Commercial, or Regional Commercial Director opportunity — in Singapore or Australia — with an organisation where scope, fit, and impact come before everything else.